Showing results (1-10 of 483) with videos related to
Sort By:
Pageof 49
Clinical Investigation|October 29, 2011
Novel agents in Waldenström macroglobulinemiaGhayas C Issa, Irene M Ghobrial, Aldo M RoccaroCurrent Opinion in Hematology|April 27, 2011
New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemiaGhayas C Issa, Houry Leblebjian, Aldo M Roccaro, et al.Journal of Hematology & Oncology|October 9, 2010
Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biologyAntonio Sacco, Ghayas C Issa, Yong Zhang, et al.Epigenomics|November 30, 2011
Epigenetics in Waldenström's macroglobulinemiaAntonio Sacco, Irene M Ghobrial, Aldo M RoccaroCurrent Cancer Drug Targets|February 17, 2017
Multiple Myeloma and the Immune MicroenvironmentYawara Kawano, Aldo M Roccaro, Irene M Ghobrial, et al.Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
Targeted therapies in Waldenström macroglobulinemiaNicholas Burwick, Aldo M Roccaro, Xavier Leleu, et al.Open Journal of Hematology|June 14, 2013
Cell Trafficking in Multiple MyelomaGiada Bianchi, Shaji Kumar, Irene M Ghobrial, et al.Cancer Letters|December 15, 2015
Targeting SDF-1 in multiple myeloma tumor microenvironmentJuliette M C Bouyssou, Irene M Ghobrial, Aldo M RoccaroSeminars in Hematology|January 15, 2011
Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myelomaKatherine R Calvo, Ola Landgren, Aldo M Roccaro, et al.Current Opinion in Hematology|April 22, 2016
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myelomaSalomon Manier, Yawara Kawano, Giada Bianchi, et al.Pageof 49